Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 8 years
- Director since
- 2023
8 years of board service in total across 3 boards, counting each seat separately. Longest: Seres Therapeutics Inc., 3 years.
Seres Therapeutics Inc.
Director
Becton Dickinson and Company
Director
Waters Corporation
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Waters Corporation May 21, 202699.9%
-
Becton Dickinson and Company January 27, 202696.4%
-
Becton Dickinson and Company January 28, 202595.3%
-
Becton Dickinson and Company January 23, 202495.9%
-
Seres Therapeutics Inc. June 22, 202399.8%
-
Becton Dickinson and Company January 24, 202397.0%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 25, 2026 | Waters Corporation | Grant or award | +358 | — | — |
| Sep 10, 2025 | Becton Dickinson and Company | Open-market sale | −917 | $187.50 | $171,938 |
| Aug 8, 2025 | Becton Dickinson and Company | Open-market sale | −863 | $192.30 | $165,955 |
| Jan 28, 2025 | Becton Dickinson and Company | Grant or award | +930 | — | — |
| Jan 23, 2024 | Becton Dickinson and Company | Grant or award | +900 | — | — |
| Aug 28, 2023 | Becton Dickinson and Company | Open-market sale | −848 | $281.66 | $238,848 |
| Jan 26, 2023 | Becton Dickinson and Company | Grant or award | +848 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.